ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ)
$88.59 -0.53 (-0.5947%)
Analysed ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) News Sources
People Living with Familial Chylomicronaemia Syndrome (FCS) in Germany Have Access to REDEMPLO® (plozasiran) as a New Treatment Option to Reduce Triglycerides
17-08-2026
yahoo.com
ARWR Stock Clocks Best Day In Nearly 8 Months As Analyst Lifts Price Target On Plozasiran Data
22-07-2026
stocktwits.com
Is Arrowhead Pharmaceuticals Stock A Smart Buy After Its Transition To A Commercial Company?
23-07-2026
trefis.com
The 'Best-Case Scenario' That Shot Arrowhead Stock Sky-High
23-07-2026
yahoo.com
Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia
27-07-2026
yahoo.com
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
03-08-2026
yahoo.com
Arrowhead Pharmaceuticals Q3 Earnings Call Highlights
04-08-2026
marketbeat.com
Arrowhead Pharmaceuticals Inc (ARWR) (Q3 2026) Earnings Call Highlights: Strong Phase III Data ...
05-08-2026
yahoo.com
ARWR: Acquires PRV for sNDA Submission for Plozasiran in sHTG
05-08-2026
yahoo.com
Arrowhead Pharmaceuticals to Present New Clinical Data at the European Society of Cardiology Congress
24-08-2026
yahoo.com
What is the current price of ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ)?
The current price of ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) is $88.59.
ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) since the previous trading day is $-0.53.
ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) since the previous trading day is -0.5947%.
What is the most recent average sentiment score for ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ)?
The most recent average sentiment score for ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ)?
The most recent sentiment for ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) is .
SEC-8K** Filing Available For ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.